EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations

David Twesigomwe iD, Britt I Drögemöller iD, Galen E B Wright iD, Clement Adebamowo, Godfred Agongo, Palwendé R Boua iD, Mogomotsi Matshaba, Maria Paximadis, Michèle Ramsay iD, Gustave Simo iD, Martin C Simuunza, Caroline T Tiemessen iD und 2 weitere

Clinical Pharmacology & Therapeutics · 2023-03 · 113 (3) · 643-659

DOI: 10.1002/cpt.2749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 21.10.2022. Verfasst von David Twesigomwe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Pharmacogenetics. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, NIAID NIH HHS, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytochrome P450 2D6 (CYP2D6) is a key enzyme in drug response owing to its involvement in the metabolism of ~ 25% of clinically prescribed medications. The encoding CYP2D6 gene is highly polymorphic, and many pharmacogenetics studies have been performed worldwide to investigate the distribution of CYP2D6 star alleles (haplotypes); however, African populations have been relatively understudied to date. In this study, the distributions of CYP2D6 star alleles and predicted drug metabolizer phenotypes—derived from activity scores—were examined across multiple sub‐Saharan African populations based on bioinformatics analysis of 961 high‐depth whole genome sequences. This was followed by characterization of novel star alleles and suballeles in a subset of the participants via targeted high‐fidelity Single‐Molecule Real‐Time resequencing (Pacific Biosciences). This study revealed varying frequencies of known CYP2D6 alleles and predicted phenotypes across different African ethnolinguistic groups. Twenty‐seven novel CYP2D6 star alleles were predicted computationally and two of them were further validated. This study highlights the importance of studying variation in key pharmacogenes such as CYP2D6 in the African context to better understand population‐specific allele frequencies. This will aid in the development of better genotyping panels and star allele detection approaches with a view toward supporting effective implementation of precision medicine strategies in Africa and across the African diaspora.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2D6PharmacogeneticsHumansGene FrequencyHaplotypesPhenotypeAllelesAfrica South of the SaharaGenotype

Substanzen

Cytochrome P-450 CYP2D6

Autor:innen und Institutionen

  • Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Division of Human Genetics, National Health Laboratory Service, and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Neuroscience Research Program, Kleysen Institute for Advanced Medicine, Winnipeg Health Sciences Centre and Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Institute for Human Virology, Abuja, Nigeria.

ORCID-Profile: David Twesigomwe, Britt I Drögemöller, Galen E B Wright, Palwendé R Boua, Michèle Ramsay, Gustave Simo, Caroline T Tiemessen, Zané Lombard, Scott Hazelhurst

Förderung

  • NHGRI NIH HHS
  • NIAID NIH HHS
  • Wellcome Trust
  • South African Medical Research Council
  • University of the Witwatersrand, Johannesburg
  • National Institutes of Health
  • National Research Foundation
  • GlaxoSmithKline

Zitieren

APA

Twesigomwe, D., Drögemöller, B. I., Wright, G. E. B., Adebamowo, C., Agongo, G., Boua, P. R., Matshaba, M., Paximadis, M., Ramsay, M., Simo, G., Simuunza, M. C., Tiemessen, C. T., Lombard, Z., & Hazelhurst, S. (2023). Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations. Clinical Pharmacology & Therapeutics, 113(3), 643-659. https://doi.org/10.1002/cpt.2749

Vancouver

Twesigomwe D, Drögemöller BI, Wright GEB, Adebamowo C, Agongo G, Boua PR, et al. Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations. Clinical Pharmacology & Therapeutics. 2023;113(3):643-659. doi:10.1002/cpt.2749

BibTeX
@article{Twesigomwe2023,
  author = {Twesigomwe, David and Drögemöller, Britt I and Wright, Galen E B and Adebamowo, Clement and Agongo, Godfred and Boua, Palwendé R and Matshaba, Mogomotsi and Paximadis, Maria and Ramsay, Michèle and Simo, Gustave and Simuunza, Martin C and Tiemessen, Caroline T and Lombard, Zané and Hazelhurst, Scott},
  title = {Characterization of CYP2D6 Pharmacogenetic Variation in Sub‐Saharan African Populations},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  volume = {113},
  number = {3},
  pages = {643--659},
  doi = {10.1002/cpt.2749}
}
Kostenlos starten →